226 related articles for article (PubMed ID: 38422019)
41. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.
Tsai FY; Orkin SH
Blood; 1997 May; 89(10):3636-43. PubMed ID: 9160668
[TBL] [Abstract][Full Text] [Related]
42. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
[TBL] [Abstract][Full Text] [Related]
43. GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis.
Katayama S; Suzuki M; Yamaoka A; Keleku-Lukwete N; Katsuoka F; Otsuki A; Kure S; Engel JD; Yamamoto M
Blood; 2017 Aug; 130(7):908-919. PubMed ID: 28630119
[TBL] [Abstract][Full Text] [Related]
44. The role of the GATA2 transcription factor in normal and malignant hematopoiesis.
Vicente C; Conchillo A; García-Sánchez MA; Odero MD
Crit Rev Oncol Hematol; 2012 Apr; 82(1):1-17. PubMed ID: 21605981
[TBL] [Abstract][Full Text] [Related]
45. Two effects of GATA2 enhancer repositioning by 3q chromosomal rearrangements.
Suzuki M; Katayama S; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):159-169. PubMed ID: 31820561
[TBL] [Abstract][Full Text] [Related]
46. A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins.
West RR; Bauer TR; Tuschong LM; Embree LJ; Calvo KR; Tillo D; Davis J; Holland SM; Hickstein DD
Blood Adv; 2023 Oct; 7(20):6351-6363. PubMed ID: 37595058
[TBL] [Abstract][Full Text] [Related]
47. GATA-related hematologic disorders.
Shimizu R; Yamamoto M
Exp Hematol; 2016 Aug; 44(8):696-705. PubMed ID: 27235756
[TBL] [Abstract][Full Text] [Related]
48. Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo.
Dyer KD; Czapiga M; Foster B; Foster PS; Kang EM; Lappas CM; Moser JM; Naumann N; Percopo CM; Siegel SJ; Swartz JM; Ting-De Ravin S; Rosenberg HF
J Immunol; 2007 Aug; 179(3):1693-9. PubMed ID: 17641035
[TBL] [Abstract][Full Text] [Related]
49. GATA2 hypomorphism induces chronic myelomonocytic leukemia in mice.
Harada N; Hasegawa A; Hirano I; Yamamoto M; Shimizu R
Cancer Sci; 2019 Apr; 110(4):1183-1193. PubMed ID: 30710465
[TBL] [Abstract][Full Text] [Related]
50. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
51. GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm.
Castaño J; Aranda S; Bueno C; Calero-Nieto FJ; Mejia-Ramirez E; Mosquera JL; Blanco E; Wang X; Prieto C; Zabaleta L; Mereu E; Rovira M; Jiménez-Delgado S; Matson DR; Heyn H; Bresnick EH; Göttgens B; Di Croce L; Menendez P; Raya A; Giorgetti A
Stem Cell Reports; 2019 Sep; 13(3):515-529. PubMed ID: 31402335
[TBL] [Abstract][Full Text] [Related]
52. Domain-specific biological functions of the transcription factor Gata2 on hematopoietic differentiation of mouse embryonic stem cells.
Kitajima K; Kanokoda M; Nakajima M; Hara T
Genes Cells; 2018 Sep; 23(9):753-766. PubMed ID: 30088690
[TBL] [Abstract][Full Text] [Related]
53. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
54. GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.
Kamata M; Okitsu Y; Fujiwara T; Kanehira M; Nakajima S; Takahashi T; Inoue A; Fukuhara N; Onishi Y; Ishizawa K; Shimizu R; Yamamoto M; Harigae H
Haematologica; 2014 Nov; 99(11):1686-96. PubMed ID: 25150255
[TBL] [Abstract][Full Text] [Related]
55. TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.
Heyes E; Wilhelmson AS; Wenzel A; Manhart G; Eder T; Schuster MB; Rzepa E; Pundhir S; D'Altri T; Frank AK; Gentil C; Woessmann J; Schoof EM; Meggendorfer M; Schwaller J; Haferlach T; Grebien F; Porse BT
Nat Commun; 2023 Oct; 14(1):6185. PubMed ID: 37794021
[TBL] [Abstract][Full Text] [Related]
56. GATA2 deficiency.
Hsu AP; McReynolds LJ; Holland SM
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):104-9. PubMed ID: 25397911
[TBL] [Abstract][Full Text] [Related]
57. Impairment of the Hypothalamus-Pituitary-Thyroid Axis Caused by Naturally Occurring
Sakai Y; Ohba K; Sasaki S; Matsushita A; Nakamura HM; Kuroda G; Tsuriya D; Yamashita M; Suda T
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576178
[TBL] [Abstract][Full Text] [Related]
58. Deletion of a conserved Gata2 enhancer impairs haemogenic endothelium programming and adult Zebrafish haematopoiesis.
Dobrzycki T; Mahony CB; Krecsmarik M; Koyunlar C; Rispoli R; Peulen-Zink J; Gussinklo K; Fedlaoui B; de Pater E; Patient R; Monteiro R
Commun Biol; 2020 Feb; 3(1):71. PubMed ID: 32054973
[TBL] [Abstract][Full Text] [Related]
59. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies.
Leubolt G; Redondo Monte E; Greif PA
IUBMB Life; 2020 Jan; 72(1):151-158. PubMed ID: 31785092
[TBL] [Abstract][Full Text] [Related]
60. Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis.
Kidoya H; Muramatsu F; Shimamura T; Jia W; Satoh T; Hayashi Y; Naito H; Kunisaki Y; Arai F; Seki M; Suzuki Y; Osawa T; Akira S; Takakura N
Nat Commun; 2019 Mar; 10(1):1072. PubMed ID: 30842549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
